Jean Jacques Lebrun
Breast cancer; metastasis; drug resistance; cancer stem cells; TGFβ signaling; melanoma; genome-wide CRISPR/Cas screens; microRNAs in cancer; precision oncology

Breast cancer; metastasis; drug resistance; cancer stem cells; TGFβ signaling; melanoma; genome-wide CRISPR/Cas screens; microRNAs in cancer; precision oncology